{"database": "lobbying", "table": "lobbying_activities", "rows": [[3533324, "bdee4922-d6cd-477e-a75b-e4c82cd18eab", "Q1", "CHAMBER HILL STRATEGIES", 400645947, "MAYO COLLABORATIVE SERVICES, INC.", 2025, "first_quarter", "MED", "Issues impacting diagnostics including FDA regulation of laboratory developed tests; H.R.2369, VALID Act of 2023", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2025-04-12T18:04:45-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3533324"], "units": {}, "query_ms": 0.5988420452922583, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}